Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and AspirinA Randomized Controlled Trial

JAMA ◽

10.1001/jama.292.1.55 ◽

2004 ◽

Vol 292 (1) ◽

pp. 55 ◽

Author(s):

Michael A. Blazing

Keyword(s):

Randomized Controlled Trial ◽

Unfractionated Heparin ◽

Acute Coronary Syndromes ◽

Controlled Trial ◽

Safety And Efficacy ◽

St Segment Elevation ◽

Randomized Controlled ◽

Coronary Syndromes

Download Full-text

Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and Aspirin: A Randomized Controlled Trial—Correction

JAMA ◽

10.1001/jama.292.10.1178 ◽

2004 ◽

Vol 292 (10) ◽

pp. 1178 ◽

Keyword(s):

Randomized Controlled Trial ◽

Unfractionated Heparin ◽

Acute Coronary Syndromes ◽

Controlled Trial ◽

Safety And Efficacy ◽

St Segment Elevation ◽

Randomized Controlled ◽

Coronary Syndromes

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108680.581591 ◽

2008 ◽

Author(s):

Michel Bertrand

Keyword(s):

Unfractionated Heparin ◽

Acute Coronary Syndromes ◽

Safety And Efficacy ◽

Invasive Strategy ◽

St Segment Elevation ◽

Coronary Syndromes

Download Full-text

Safety and efficacy of enoxaparin vs. unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes. who receive tirofiban and aspirin

ACC Current Journal Review ◽

10.1016/j.accreview.2004.08.005 ◽

2004 ◽

Vol 13 (9) ◽

pp. 9

Author(s):

M.A. Blazing ◽

J.A. de Lemos ◽

H.D. White

Keyword(s):

Unfractionated Heparin ◽

Acute Coronary Syndromes ◽

Safety And Efficacy ◽

St Segment Elevation ◽

Coronary Syndromes

Download Full-text

Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb/IIIa Inhibitor Eptifibatide

Circulation ◽

10.1161/01.cir.0000050144.67910.13 ◽

2003 ◽

Vol 107 (2) ◽

pp. 238-244 ◽

Author(s):

Shaun G. Goodman ◽

David Fitchett ◽

Paul W. Armstrong ◽

Mary Tan ◽

Anatoly Langer

Keyword(s):

High Risk ◽

Unfractionated Heparin ◽

Acute Coronary Syndromes ◽

Safety And Efficacy ◽

St Segment Elevation ◽

High Risk Patients ◽

Randomized Evaluation ◽

Risk Patients ◽

Coronary Syndromes

Download Full-text

Randomized evaluation of the safety and efficacy of enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

ACC Current Journal Review ◽

10.1016/s1062-1458(03)00186-7 ◽

2003 ◽

Vol 12 (3) ◽

pp. 65

Author(s):

S.G. Goodman ◽

D. Fitchett ◽

P.W. Armstrong ◽

M. Tan ◽

A. Langer

Keyword(s):

High Risk ◽

Unfractionated Heparin ◽

Acute Coronary Syndromes ◽

Safety And Efficacy ◽

St Segment Elevation ◽

High Risk Patients ◽

Randomized Evaluation ◽

Risk Patients ◽

Coronary Syndromes

Download Full-text

A single-center prospective randomized controlled trial evaluating the safety and efficacy of IntraCoronary Erythropoietin delivery BEfore Reperfusion: Gauging infarct size in patients with acute ST-segment elevation myocardial infarction. Study design and rationale of the ‘ICEBERG Trial’11Trial registration: http://www.ClinicalTrials.gov identifier: NCT01538771.

Contemporary Clinical Trials ◽

10.1016/j.cct.2013.03.001 ◽

2013 ◽

Vol 35 (1) ◽

pp. 145-150 ◽

Author(s):

Jung-Won Suh ◽

Yeonyee E. Yoon ◽

Il-Young Oh ◽

Chang-Hwan Yoon ◽

Young-Seok Cho ◽

...

Keyword(s):

Myocardial Infarction ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Single Center ◽

Safety And Efficacy ◽

St Segment Elevation ◽

Segment Elevation Myocardial Infarction ◽

Randomized Controlled ◽

Prospective Randomized Controlled Trial

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108680.564774 ◽

2008 ◽

Author(s):

Harold Dauerman

Keyword(s):

Unfractionated Heparin ◽

Acute Coronary Syndromes ◽

Safety And Efficacy ◽

Invasive Strategy ◽

St Segment Elevation ◽

Coronary Syndromes

Download Full-text

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2007.12.052 ◽

2008 ◽

Vol 51 (18) ◽

pp. 1734-1741 ◽

Author(s):

Harvey D. White ◽

Derek P. Chew ◽

James W. Hoekstra ◽

Chadwick D. Miller ◽

Charles V. Pollack ◽

...

Keyword(s):

Unfractionated Heparin ◽

Acute Coronary Syndromes ◽

Safety And Efficacy ◽

Invasive Strategy ◽

St Segment Elevation ◽

Coronary Syndromes

Download Full-text

Low-molecular-weight heparin compared with unfractionated heparin for patients with non–ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: Results from the CRUSADE initiative

Journal of Thrombosis and Thrombolysis ◽

10.1007/s11239-006-5708-0 ◽

2006 ◽

Vol 21 (3) ◽

pp. 211-220 ◽

Author(s):

Kanwar P. Singh ◽

◽

Matthew T. Roe ◽

Eric D. Peterson ◽

Anita Y. Chen ◽

...

Keyword(s):

Molecular Weight ◽

Unfractionated Heparin ◽

Acute Coronary Syndromes ◽

Low Molecular Weight Heparin ◽

Low Molecular Weight ◽

St Segment Elevation ◽

Coronary Syndromes

Download Full-text

Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled Trial

JAMA ◽

10.1001/jama.285.13.1711 ◽

2001 ◽

Vol 285 (13) ◽

pp. 1711 ◽

Cited By ~ 1654

Author(s):

Gregory G. Schwartz

Keyword(s):

Randomized Controlled Trial ◽

Acute Coronary Syndromes ◽

Controlled Trial ◽

Randomized Controlled ◽

Coronary Syndromes ◽

Ischemic Events

Download Full-text